Skip to content

Clinical research on metabolic syndrome population based on intestinal microecological regulation

Clinical research on metabolic syndrome population based on intestinal microecological regulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114169
Enrollment
Unknown
Registered
2025-12-08
Start date
2025-12-08
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome

Interventions

control :Lifestyle intervention
experimental :Lifestyle + probiotics + prebiotic intervention

Sponsors

Shulan (Hangzhou) Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18 - 65 years old, gender not restricted 2. Sign the informed consent form 3. Those meeting the diagnostic criteria for metabolic syndrome (refer to the International Diabetes Federation IDF 2005)

Exclusion criteria

Exclusion criteria: 1. Those with severe disorders of the heart, liver and kidneys, or malignant tumors. 2. Those who have taken drugs that can alter the intestinal microecology and body metabolism within the last 4 weeks, such as antibiotics, antiviral drugs, probiotic-related preparations, cytotoxic drugs, hormones, etc. 3. Those who have participated in other clinical studies within the last 4 weeks or are currently participating in such studies. 4. Those with digestive system diseases such as inflammatory bowel disease, irritable bowel syndrome, chronic diarrhea, etc. 5. Pregnant or lactating women. 6. Those with an unstable dietary history, defined as significant changes in diet within the last month, including a reduction or significant increase in the main food groups in the diet of the subjects. 7. Those with a long-term and heavy drinking history. 8. The researchers consider that they have other conditions that make them unsuitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Change rate of HOMA-IR;Improvement rate of metabolic indicators;

Secondary

MeasureTime frame
Changes in Gut Microbiota Abundance and Diversity;

Countries

China

Contacts

Public ContactXiahong Dai

Shulan (Hangzhou) Hospital

daixh0630@163.com+86 135 8806 2672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026